View More Recent Stories

Sep 18, 2020 07:00AM Deciphera Presents Data from QINLOCK™ (Ripretinib) Program in Patients with Gastrointestinal Stromal Tumor at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
Sep 17, 2020 07:05AM Deciphera Pharmaceuticals (DCPH) Highlights Data from Rebastinib TIE2 Inhibitor Program at ESMO Virtual Meetings 2020
Sep 17, 2020 07:00AM Deciphera Presents Data from Rebastinib, its TIE2 Inhibitor Program, at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 
Aug 17, 2020 04:30PM Deciphera Pharmaceuticals (DCPH) Announces Publication of QINLOCK Phase 1 Study Results in Patients with Gastrointestinal Stromal Tumor in Journal of Clinical Oncology
Aug 17, 2020 04:30PM Deciphera Announces Publication of QINLOCK™ (ripretinib) Phase 1 Study Results in Patients with Gastrointestinal Stromal Tumor in Journal of Clinical Oncology
Aug 6, 2020 08:40AM Deciphera Pharmaceuticals, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
Aug 4, 2020 04:05PM Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results
Jul 29, 2020 07:00AM Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 4, 2020
Jul 20, 2020 07:34AM Zai Lab (ZLAB), Deciphera Pharmaceuticals (DCPH) Announce China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
Jul 20, 2020 07:30AM China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
Jul 20, 2020 07:30AM China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
Jun 5, 2018 09:22AM Pre-Open Movers 06/05: (CODX) (GIII) (RGLS) Higher; (ANW) (FRAN) (ASNA) Lower (more...)
Jun 4, 2018 05:36PM After-Hours Stock Movers 06/04: (TWTR) (MYL) (NX) Higher; (ANW) (ASNA) (COOL) Lower (more...)
Nov 14, 2017 10:00AM Deciphera Pharmaceuticals, Inc. (Nasdaq: DCPH) to Ring The Nasdaq Stock Market Opening Bell
View More Recent Stories